Clinical Trials Sponsored by Lundbeck Foundation

Total 16192 results

H. Lundbeck A/S

Completed

Adult Primary Insomnia Polysomnographic Study (0928-004)(COMPLETED)

Primary Insomnia
H. Lundbeck A/S

Terminated

Sleep Laboratory Study of MK0928 in Adult Patients With Primary Insomnia (0928-041)(TERMINATED)

Primary Insomnia
H. Lundbeck A/S

Completed

Efficacy and Safety of MK0928 for Insomnia in Adults (0928-003)(COMPLETED)

Insomnia
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA39959 in Patients With Bipolar Depression

Bipolar Disorder

United States
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Venlafaxine-referenced Study of Efficacy and Safety of 5 and 10 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
H. Lundbeck A/S

Completed

Efficacy of Vortioxetine (Lu AA21004) in the Prevention of Relapse of Major Depressive Episodes

Major Depressive Disorder
H. Lundbeck A/S

Completed

A Study of Vortioxetine (Lu AA21004) in Comparison to Agomelatine in Adults Suffering From Major Depression With Inadequate Response to Previous Medication (REVIVE)

Major Depressive Disorder
H. Lundbeck A/S

Completed

Absolute Bioavailability of Lu AE58054 in Healthy Subjects

Healthy

United Kingdom
H. Lundbeck A/S

Completed

Randomised Placebo-controlled Duloxetine-referenced Study of Efficacy and Safety of 15 and 20 mg of Vortioxetine (Lu AA21004) in Acute Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 15 and 20 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
H. Lundbeck A/S

Completed

Open-label Safety Extension Study of 5 and 10 mg of Vortioxetine (Lu AA21004) in Long-term Treatment of Major Depressive Disorder in Adults

Major Depressive Disorder
H. Lundbeck A/S

Completed

Sertindole in Asian Patients With Schizophrenia

Schizophrenia

China
H. Lundbeck A/S

Completed

Efficacy of Nalmefene in Patients With Alcohol Dependence (ESENSE2)

Alcohol Dependence

Poland, Belgium, Czech Republic, France, Italy, Portugal, Spain
H. Lundbeck A/S

Completed

Pharmacokinetic Properties of Lu AA21004 (Vortioxetine) in Healthy Young Chinese Men and Women

Healthy

China
H. Lundbeck A/S

Completed

Short-term Study of Combination Treatment of Escitalopram and Gaboxadol in Major Depressive Disorder

Major Depressive Disorder

Austria, Russian Federation
H. Lundbeck A/S

Completed

Bioequivalence Study Comparing Two Formulations of Escitalopram

Healthy

Netherlands
H. Lundbeck A/S

Completed

A Clinical Study Evaluating the Effects of Memantine on Brain Atrophy in Patients With Alzheimer's Disease

Alzheimer's Disease
H. Lundbeck A/S

Terminated

Safety and Tolerability of Memantine in Moderate to Severe Alzheimer's Disease

Alzheimer's Disease

Canada
H. Lundbeck A/S

Completed

Lu AE58054 Added to Donepezil for the Treatment for Moderate Alzheimer's Disease

Alzheimer's Disease

Spain, Germany, Australia, Canada, Czech Republic, Italy, Poland
H. Lundbeck A/S

Completed

Escitalopram in Patients With Generalized Anxiety Disorder

Generalized Anxiety Disorder

Russian Federation
H. Lundbeck A/S

Completed

Escitalopram in Patients With Social Anxiety Disorder

Social Anxiety Disorder

Russian Federation
H. Lundbeck A/S

Terminated

Efficacy and Safety of Lu AA34893 in Patients With Major Depressive Disorder

Major Depressive Disorder

Canada
H. Lundbeck A/S

Completed

A Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Sweden
H. Lundbeck A/S

Completed

A Prospective Open-Label Extension Study of Gaboxadol in Primary Insomnia

Primary Insomnia

Germany
H. Lundbeck A/S

Recruiting

A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

Healthy Participants

China
H. Lundbeck A/S

Recruiting

Study of Lu AG13909 in Participants With Congenital Adrenal Hyperplasia

Congenital Adrenal Hyperplasia

United Kingdom
H. Lundbeck A/S

Recruiting

A Study With Eptinezumab in Children and Adolescents (6 to 17 Years) With Chronic or Episodic Migraine (REJOIN)

Migraine

Spain, Italy, Serbia, United States, Argentina, Mexico, Canada, United Kingdom
H. Lundbeck A/S

Active, not recruiting

A Trial Investigating Lu AF28996 in Healthy Adult Participants

Healthy Participants

United States
H. Lundbeck A/S

Completed

Observational Study in Multiple System Atrophy (TALISMAN)

Multiple System Atrophy

China
H. Lundbeck A/S

Completed

Study in Healthy Subjects to Compare Two Tablet Formulations of Memantine (Ebixa®) in Fasted and Fed Conditions

Healthy

China
H. Lundbeck A/S

Active, not recruiting

A Study of Lu AF82422 in Participants With Multiple System Atrophy (AMULET)

Multiple System Atrophy

United States, Japan
H. Lundbeck A/S

Completed

A Trial Investigating Lu AF28996 in Adult Japanese Participants With Parkinson's Disease (PD)

Parkinson Disease

Japan
H. Lundbeck A/S

Completed

Eptinezumab in Participants With Episodic Cluster Headache (ALLEVIATE)

Cluster Headache, Episodic

Spain, United States, Germany, Portugal, Italy, Netherlands, Finland, Belgium, Czechia, Denmark, France, Georgia, Russian Federation, United Kingdom, Greece, Estonia, Japan, Norway, Sweden
H. Lundbeck A/S

Completed

A Study to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Participants That Are Not Helped by Previous Preventive Treatments (DELIVER)

Migraine

Spain, United States, Bulgaria, Hungary, Germany, Poland, Georgia, Belgium, Finland, Czechia, Denmark, France, Italy, Russian Federation, Slovakia, Sweden, United Kingdom
H. Lundbeck A/S

Completed

Study With Lu AF87908 in Healthy Participants and Participants With Alzheimer's Disease

Healthy | Alzheimer Disease

United States
H. Lundbeck A/S

Completed

A 1-year Trial to Inform About Long-term Exposure to Eptinezumab in Participants With Chronic Cluster Headache (cCH) (CHRONICLE)

Chronic Cluster Headache

Spain, Germany, United Kingdom, United States, Netherlands, Denmark, Finland, France, Italy
H. Lundbeck A/S

Completed

Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)

PTSD

United States
H. Lundbeck A/S

Completed

Safety and Tolerability of Lu AG06474 in Healthy Young Men

Healthy

United States
H. Lundbeck A/S

Terminated

Long-term, Open-label, Flexible-dose, Extension Study of Vortioxetine in Child and Adolescent Participants With Major Depressive Disorder (MDD) From 7 to 18 Years of Age

Depressive Disorder, Major

United States, Korea, Republic of, Hungary, Poland, Spain, Serbia, Estonia, Bulgaria, Latvia, Russian Federation, Ukraine, Canada, Colombia, France, Germany, Israel, Italy, Mexico, South Africa, United Kingdom
H. Lundbeck A/S

Completed

A Study in Healthy Adults Investigating Eptinezumab Produced by 2 Different Manufacturing Cell Lines

Healthy Participants

United States
H. Lundbeck A/S

Completed

A Study Investigating Lu AG06466 in Healthy Men

Healthy Volunteers

United Kingdom
H. Lundbeck A/S

Completed

A Single Dose Study of Lu AG09222 in a Headache Model With Healthy Subjects

Healthy

Denmark
H. Lundbeck A/S

Completed

Lu AF82422 in Healthy Non-Japanese and Japanese Subjects and in Patients With Parkinson's Disease

Healthy | Parkinson Disease

United States
Lundbeck Japan K. K.

Completed

Clinical Study of Desmoteplase in Japanese Patients With Acute Ischemic Stroke (DIAS-J)

Acute Ischemic Stroke

Japan
H. Lundbeck A/S

Completed

Vortioxetine in Patients With Depression Coexisting With General Anxiety Disorder (GAD) (RECONNECT)

Anxiety Disorders | MDD

Estonia, France, Italy, Korea, Republic of, Poland, Spain
H. Lundbeck A/S

Completed

Binding of Lu AG06466 in the Brain in Healthy Men

Healthy

Belgium
H. Lundbeck A/S

Completed

An Exploratory Study Investigating Safety, Tolerability and Pharmacokinetics of Ascending Doses of Lu AE04621 in Parkinson Disease Patients

Parkinson Disease

United States
H. Lundbeck A/S

Completed

Flexible-dose, Long-term Safety Study of Lu AF35700 in Adult Patients With Schizophrenia (Debut)

Schizophrenia

Estonia, Mexico, Russian Federation, Serbia, Ukraine, United States, Bulgaria, Canada, Czechia, Poland, Slovakia, Spain, Romania
H. Lundbeck A/S

Terminated

Study With Lu AF11167 for the Treatment of Negative Symptoms in Patients With Schizophrenia

Schizophrenia

Bulgaria, Czechia, Estonia, Germany, Hungary, Latvia, Poland, Ukraine
H. Lundbeck A/S

Terminated

Study Investigating Effects of Foliglurax in Patients With Parkinson's Disease (PD) and Healthy Subjects

Healthy | Parkinson Disease

France

3

Subscribe